title: Leptin inhibits cell growth of human vascular smooth muscle cells.
abstract: Elevated leptin levels are thought to contribute to the individual cardiovascular risk, however, the role of leptin in the pathogenesis of atherosclerosis remains unclear. The aim of our study was to elucidate the effects of leptin on growth of human vascular smooth muscle cells (VSMC) and leptin receptor expression. By establishing a new quantitative real-time PCR for leptin receptor (ObR) isoforms we showed that the short isoforms of ObR were expressed in a 10- to 27-fold excess compared to the long isoform in cultured human VSMCs. Incubation of VSMCs with 100 ng/ml leptin downregulated the short isoforms significantly, whereas the long isoform was not influenced. Increasing leptin concentrations of 50 and 100 ng/ml significantly reduced the cell number of VSMCs compared to untreated controls. Our findings suggest a role for leptin in vascular smooth muscle cell growth, associated to a downregulation of leptin receptor isoforms.
authors.affiliation: Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital, Paul-List-Str 13-15, 04103 Leipzig, Germany.
authors.forename: Felix
authors.initials: F
authors.lastname: Bohlen
authors.forename: Juergen
authors.initials: J
authors.lastname: Kratzsch
authors.forename: Marc
authors.initials: M
authors.lastname: Mueller
authors.forename: Bert
authors.initials: B
authors.lastname: Seidel
authors.forename: Miriam
authors.initials: M
authors.lastname: Friedman-Einat
authors.forename: Helmut
authors.initials: H
authors.lastname: Witzigmann
authors.forename: Daniel
authors.initials: D
authors.lastname: Teupser
authors.forename: Antje
authors.initials: A
authors.lastname: Koerner
authors.forename: Martin
authors.initials: M
authors.lastname: Storck
authors.forename: Joachim
authors.initials: J
authors.lastname: Thiery
mesh_terms: D000368:Aged; D001011:Aorta / Q000187:drug effects; D002340:Carotid Artery Diseases / Q000378:metabolism; D002343:Carotid Artery, Internal / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation; D005260:Female; D006131:Growth Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D007083:Iliac Artery / Q000187:drug effects; D020738:Leptin / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D032389:Myocytes, Smooth Muscle / Q000187:drug effects*; D016133:Polymerase Chain Reaction / Q000379:methods; D020033:Protein Isoforms; D012333:RNA, Messenger / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000187:drug effects* / Q000378:metabolism; D054411:Receptors, Leptin
chemical_list: D006131:Growth Inhibitors; C515448:LEPR protein, human; D020738:Leptin; D020033:Protein Isoforms; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin